URGN 8-K 2026-08-20

UroGen Pharma Ltd. (URGN) 8-K dated 2026-08-20 — accession 0001437749-26-028590. This URL is the filing, not the URGN hub.

UroGen Pharma Ltd. (URGN) is a biotechnology company listed on NASDAQ.

UroGen Pharma Ltd. filed a 8-K on 2026-08-20. Accession 0001437749-26-028590.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported URGN revenue for 2025-12-31 was $109.8M. Net income was -$153.5M. URGN currently screens at market cap $1.61B.

Not investment advice. The URGN SEC hub lists recent forms. The stock page is the research view.